https://www.selleckchem.com/pr....oducts/amenamevir.ht
4 on a duplex scan or ≥ 50% stenosis on angiography. Graft restenosis was defined as a PSV 300 cm/s and velocity ratio 3.5 or uniformly low PSV less then 45 cm/s throughout the entire graft based on graft surveillance. The mean follow-up period was 36.6 ± 25.5 months. At 2 years, the rates of freedom from ReISR, ReTLR, and MALE were not significantly different between the DCS implantation and BSX groups (68.9% vs. 73.7%, p = 0.81; 84.7% vs. 73.7%, p = 0.45; 84.7% vs. 78.6%, p = 0.60, respectively). However, the freedom from re
Curtir
Comentario
Compartilhar
